AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇼

LEVETIRACETAM in Zimbabwe

9 products registered with MCAZ — 9 active

Brand / ProductReg. No.HolderStatusExpires
QUETRA
TABLET, COATED; ORAL
2026/13.1/7423REMEDICA LTDactive6 May 2031
LETRAM
TABLET; ORAL
2016/13.1/5215HETERO LABS LTDactive10 Dec 2030
TORLEVA 250
TABLET, COATED; ORAL
2016/13.1/5214TORRENT EXPORTS LTDactive9 Oct 2029
TORLEVA 500
TABLET, COATED; ORAL
2016/13.1/5213TORRENT PHARMACEUTICALSactive9 Oct 2029
KEPPROLIN
SOLUTION
2024/13.1/6547LINCOLN PHARMACEUTICALS LIMITEDactive23 Jan 2029
SYCOCETAM
TABLET, COATED; ORAL
2023/13.1/6454ORANGE HEALTH P/Lactive2 Aug 2028
LEVULEX 750
TABLET, COATED; ORAL
2024/13.1/6659COSPHARM INVESTMENTS PVT LTDactive31 Dec 2027
QUETRA
SOLUTION
2025/13.1/7212REMEDICA LTDactive31 Dec 2027
LEVULEX 500
TABLET, COATED; ORAL
2024/13.1/6658COSPHARM INVESTMENTS PVT LTDactive31 Dec 2027

LEVETIRACETAM — MCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing LEVETIRACETAM, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track LEVETIRACETAM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.